2020 annual financial data
CytomX Therapeutics 2020 Operating margin
Direct answer
Operating margin was -117.7%.
Operating income was -80,540,000 USD and net income was -64,819,999 USD.
Operating cash flow was 5,259,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 68,427,000 USD
- Operating income
- -80,540,000 USD
- Net income
- -64,819,999 USD
- Operating cash flow
- 5,259,000 USD